プリンストン、ニュージャージー：2023年6月13日 バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced the appointment of Shelia Rocchio to the position of Chief Marketing Officer. In this role, Ms. Rocchio will be responsible for leading the Certara marketing function, building data driven marketing practices, driving lead generation, and further developing Certara’s brand strategy.
“I am pleased to welcome Sheila as our new Chief Marketing Officer,” said William F. Feehery, PH.D., CEO of Certara. Her role will be vital in advancing our mission to accelerate new medicines for patients. Sheila’s extensive leadership experience and life science domain expertise will be invaluable as we continue increasing the adoption of biosimulation and other advanced technologies that transform the efficiency of the drug development process.”
Ms. Rocchio has more than 20 years of experience in marketing, product management and strategy roles in life sciences technology and services companies. Her most recent role was Chief Marketing Officer at eClinical Solutions where she managed all aspects of marketing including branding, communications, lead generation, and product marketing. Prior to joining eClinical Solutions, she held marketing and executive leadership roles at PHT Corporation where she was a driving force in commercializing and accelerating the industry adoption of innovative clinical technology.
Ms. Rocchio’s industry honors include being selected for the PharmaVOICE 100 most influential people in life sciences and as the Massachusetts Technology Leadership Council Emerging Executive of the Year. She holds a BS from MIT and an MBA from Boston College.
Certara（サターラ）について
サターラは、独自のバイオシミュレーションソフトウェア、テクノロジー、コンサルティングサービスを通して、従来の創薬・医薬品開発に変革をもたらすことをミッションとしています。2,000社の製薬企業、主要学術機関、世界各国の規制当局がサターラのソフトウェアやコンサルティングサービスを利用しております。（62か国にてビジネス展開）
